Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer
Status: | Active, not recruiting |
---|---|
Conditions: | Breast Cancer, Neurology |
Therapuetic Areas: | Neurology, Oncology |
Healthy: | No |
Age Range: | Any |
Updated: | 6/27/2018 |
Start Date: | July 2, 2015 |
End Date: | September 1, 2019 |
The Effects of a Sensorimotor Rehabilitation Program on the Upper and Lower Limbs of Persons With Cancer Following Taxane-Based Chemotherapy for Early Stage Breast Cancer
This clinical trial studies how well the sensorimotor rehabilitation program works in
improving quality of life in patients with early stage breast cancer. A hand and foot sensory
improvement program from occupational and physical therapists may improve patients' function
in everyday tasks and overall quality of life.
improving quality of life in patients with early stage breast cancer. A hand and foot sensory
improvement program from occupational and physical therapists may improve patients' function
in everyday tasks and overall quality of life.
PRIMARY OBJECTIVES:
I. To investigate the effects of an innovative, new sensorimotor rehabilitation program on
persons with cancer following taxane-based chemotherapy for early stage breast cancer.
OUTLINE:
Patients attend 1 therapy session to receive education and training in the use of the home
program. Patients then complete exercises over 90 minutes per week for 6 weeks.
I. To investigate the effects of an innovative, new sensorimotor rehabilitation program on
persons with cancer following taxane-based chemotherapy for early stage breast cancer.
OUTLINE:
Patients attend 1 therapy session to receive education and training in the use of the home
program. Patients then complete exercises over 90 minutes per week for 6 weeks.
Inclusion Criteria:
- Persons with a primary diagnosis of grade 1 or greater peripheral neuropathy of the
upper and lower extremities
- Taxane-based chemotherapy for early stage breast cancer
- Diagnosis of early stage breast cancer
Exclusion Criteria:
- Individuals with late stage breast cancer
We found this trial at
1
site
Click here to add this to my saved trials